FDA.reportPublic FDA data

bupivacaine 400 MG / meloxicam 12 MG per 14 ML Extended Release Solution

RxCUI
2560312
RxNorm name
bupivacaine 400 MG / meloxicam 12 MG per 14 ML Extended Release Solution
Display name
bupivacaine 400 MG / meloxicam 12 MG per 14 ML Extended Release Solution
Full name
bupivacaine 400 MG / meloxicam 12 MG per 14 ML Extended Release Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZYNRELEFBUPIVACAINE AND MELOXICAMHeron Therapeutics, Inc.dab484a7-9353-43ba-9e74-7fab910c712b2026-04-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2560312

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dab484a7-9353-43ba-9e74-7fab910c712bBUPivacaine 400 MG / meloxicam 12 MG in 14 ML Extended Release Solution [PSN] · 14 ML bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [SCD] · bupivacaine 400 MG / meloxicam 12 MG per 14 ML Extended Release Solution [SY]316These highlights do not include all the information needed to use ZYNRELEF ® safely and effectively. See full prescribing information for ZYNRELEF. ZYNRELEF (bupivacaine and meloxicam) extended-release solution, for instillation use Initial U.S. Approval: 202120260420